Full Text (PDF)
Review Article

Liquid Biopsy in Ovarian Cancer

Pratibha Singh, Professor, Department of Obstetrics & Gynecology All India Institute of Medical Sciences, Jodhpur, Rajasthan 342005, India. , Pratibha Singh1 , Meenakshi Gothwal2 , Garima Yadav3

Author Information

Licence:




Indian Journal of Obstetrics and Gynecology 6(4):p 427-431, July - August 2018. | DOI: DOI: http://dx.doi.org/10.21088/ijog.2321.1636.6418.16

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Ovarian cancer has always been a perplexing problem to the clinicians. Most cases are detected at an advanced stage with poor and unpredictable response to therapy. Screening of ovarian cancer in general population has not proved to the useful due to low sensitivities of the available tests. There is need for newer tests which can overcome these problems clinicians are facing. Remarkable advances in the field of genetics and molecular techniques have given clinicians a hope for not only early diagnosis but also to monitor response to therapy and detect early recurrences and resistance to drugs. Circulating cell free DNA and circulating tumour cells have given a new hope, though it still hasprove its effectiveness in routine clinical use. This article throws light on these newer developments in ovarian cancer.

Keywords: Circulating Tumour Cells; Circulating Cell Free Tumour DNA; Ovarian Cancer.


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: http://dx.doi.org/10.21088/ijog.2321.1636.6418.16

Keywords


Article Level Metrics

Last Updated

Wednesday 17 June 2026, 23:10:27 (IST)


1422

Accesses

1
152
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share